New project aims to increase the EU’s ability to combat flavivirus threats

A new project – FLAVIVACCINE – aims to increase the EU’s ability to combat epidemic and pandemic viral threats both in Europe and around the world.

PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical Trial in Lymphoma – Biotech Investments

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous Eckert & Ziegler: PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical

June 9, 2023

AI models may be using “demographic shortcuts” when making medical diagnostic evaluations

Artificial intelligence models often play a role in medical diagnoses, especially when it comes to analyzing images such as X-rays. However, studies have found that

June 28, 2024

Coherus and Junshi’s PD-1 inhibitor approved for nasopharyngeal carcinoma – Pharmaceutical Technology

Coherus licensed Loqtorzi from Junshi for marketing in the US and Canada in February 2021. Image Credit: Prostock-studio / Shutterstock. The US Food and Drug

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.